Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31, (S0302283823030737), (10.1016/j.eururo.2023.08.016)]

J Alfred Witjes*, Harman Max Bruins, Albert Carrión, Richard Cathomas, Eva Compérat, Jason A Efstathiou, Rainer Fietkau, Georgios Gakis, Anja Lorch, Alberto Martini, Laura S Mertens, Richard P Meijer, Matthew I Milowsky, Yann Neuzillet, Valeria Panebiaco, John Redlef, Michael Rink, Mathieu Rouanne, George N Thalmann, Sæbjørn SæbjørnsenErik Veskimäe, Paramananthan Mariappan, Antoine G van der Heijden

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The authors regret the oversight in the initially published version of this article, where the name of Prof. Paramananthan Mariappan, along with his affiliation to the Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, at The University of Edinburgh, Edinburgh, United Kingdom, was inadvertently omitted from the author list. This has now been updated. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article numbere180
JournalEuropean Urology
Volume85
Issue number6
Early online date15 Mar 2024
DOIs
Publication statusPublished - Jun 2024

Fingerprint

Dive into the research topics of 'Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31, (S0302283823030737), (10.1016/j.eururo.2023.08.016)]'. Together they form a unique fingerprint.

Cite this